Astellas Pharma Inc: Dermatitis, Atopic trials

The registry lists 18 Dermatitis, Atopic studies with Astellas Pharma Inc as lead sponsor. 0 are open to participants now and 0 have results posted.

Phase 2 4Phase 3 6Phase 4 8(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Preventive Treatment of Tacrolimus Ointment in Children With Atopic DermatitisCompletedNCT01745159Phase 4
• Equivalence of the Response to Vaccination of Tacrolimus Ointment to a Steroid Ointment Regimen in Children With Atopic DermatitisCompletedNCT00801957Phase 2
• Study to Evaluate the Response to Treatment and Safety of 0.03% Tacrolimus (FK506) Ointment Administered in Pediatric Patients With Moderate to Severe Atopic DermatitisCompletedNCT00691262Phase 3
• Study to Evaluate the Efficacy and Safety of 0.1% and 0.03% Tacrolimus Ointment Administered in Adults With Moderate to Severe Atopic DermatitisCompletedNCT00691145Phase 3
• Protopic Ointment in Adult Atopic Eczema of the FaceCompletedNCT00690105Phase 4
• Protopic Ointment in Children Atopic EczemaCompletedNCT00689832Phase 4
• Locobase® REPAIR Used as an Adjunctive to Standard Therapy in Children With Moderate to Severe Atopic DermatitisCompletedNCT00673725Phase 4
• Comparison Study Between Protopic (Tacrolimus Ointment) and Elidel (Pimecrolimus Cream) in Pediatric Patients With Mild Atopic DermatitisCompletedNCT00667160Phase 4
• A Comparison Study Between Protopic (Tacrolimus) Ointment and Elidel (Pimecrolimus) Cream in Treating Subjects With Atopic DermatitisCompletedNCT00666302Phase 4
• Comparison Study Between Protopic (Tacrolimus Ointment) and Elidel (Pimecrolimus Cream) in Treating Pediatric Patients With Atopic DermatitisCompletedNCT00666159Phase 4
• Long-term Safety of Protopic in Atopic EczemaCompletedNCT00560378Phase 3
• Tacrolimus Ointment Long Term Safety in Young Children With Atopic DermatitisCompletedNCT00560326Phase 2
• Tacrolimus Ointment Pharmacokinetics in Infants With Atopic DermatitisCompletedNCT00535691Phase 2
• Distribution of Tacrolimus in Skin, Atopic DermatitisCompletedNCT00534508Phase 2
• Clinical Trial to Assess the Efficacy and Safety of Tacrolimus Ointment Treatment of Atopic Dermatitis in Adult PatientsCompletedNCT00523952Phase 3
• Treatment and Control of Atopic Dermatitis With 0.03% Tacrolimus OintmentCompletedNCT00480896Phase 3
• Treatment and Control of Atopic Dermatitis With 0.1% Tacrolimus OintmentCompletedNCT00480610Phase 3
• A Multi-Center Study of Short and Long-term Use of Protopic Ointment in Patients With Atopic DermatitisCompletedNCT00106496Phase 4